A Study of Mitoguazone Dihydrochloride in Patients With AIDS-Related Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To estimate the response rate, response duration, clinical benefit, and toxicity of
mitoguazone dihydrochloride (MGBG) in patients with AIDS-related refractory or relapsing
non-Hodgkin's lymphoma (NHL).